REMSleep Holdings, Inc. (RMSL)
OTCMKTS · Delayed Price · Currency is USD
0.0055
-0.0003 (-5.17%)
Aug 15, 2025, 3:57 PM EDT
REMSleep Holdings Market Cap
REMSleep Holdings has a market cap or net worth of $8.32 million as of August 15, 2025. Its market cap has decreased by -38.96% in one year.
Market Cap
8.32M
Enterprise Value
8.06M
Revenue
36.53K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since June 8, 2010, REMSleep Holdings's market cap has decreased from 45.32M to 8.32M, a decrease of -81.63%. That is a compound annual growth rate of -10.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 8.32M | -34.17% |
| Dec 31, 2024 | 12.65M | -44.18% |
| Dec 29, 2023 | 22.66M | 24.00% |
| Dec 30, 2022 | 18.27M | 16.26% |
| Dec 31, 2021 | 15.71M | 1,001.06% |
| Dec 31, 2020 | 1.43M | 36.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 606.72M |
| Elite Pharmaceuticals | 567.29M |
| American Oncology Network | 389.51M |
| Northwest Biotherapeutics | 351.78M |
| CytoDyn | 336.73M |